Why did 4572.T stock jump in the pre-market?

The pre-market jump to JPY 497.00 reflects event-driven buying. Volume rose to 878000.00 shares. Market participants likely reacted to collaboration or clinical updates and positioned ahead of the 2026-02-10 earnings announcement.

What are the main valuation metrics for Carna Biosciences (4572.T)?

Key metrics: EPS -113.67, PE -3.67, P/S 14.63, P/B 9.22. Cash per share is 48.40 JPY and current ratio is 9.18. These show high liquidity but weak profitability.

What does Meyka AI forecast for 4572.T stock?

Meyka AI's forecast model projects a monthly level of JPY 386.68 and a quarterly level of JPY 209.09. Compared with the current JPY 497.00, the monthly model implies about -22.26% downside. Forecasts are not guarantees.

How should traders approach 4572.T stock after this move?

Traders should use tight risk controls. The ADX at 53.85 shows a strong trend. Consider partial profit-taking and stop-loss limits, especially given negative earnings and high valuation multiples.

JP Stocks

Pre-market: 4572.T Carna Biosciences (JPX) jumps 27.76% on news: what traders should watch

ByHuzaifa Zahoor January 19, 2026

The 4572.T stock surged in pre-market trading to JPY 497.00, up 27.76% from the previous close of JPY 389.00. Volume is active at 878000.00 shares versus an average of 665079.00, marking this session’s top gainer on the JPX. Traders are pricing new catalysts ahead of a 2026-02-10 earnings announcement. Below we unpack the drivers, valuation, technicals, Meyka AI grade, and a model forecast to help investors frame the move.